# Dyne Therapeutics, Inc.: insider transactions

DYN · Nasdaq · CIK 1818794 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dyn.md) · [Financials](/companies/dyn/financials.md) · [Filings](/companies/dyn/filings.md) · [Insiders](/companies/dyn/insiders.md)

## All transactions: 1

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-20 | [Kerr Douglas](/insiders/1814189.md) | Head of R&D and CMO, Officer | Grant or award (A) | 8,000 | $0.00 | $0 | [Form 4](/filings/0001814189-26-000007.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.